The diabetes market in Kenya is expected to grow by 6.8% on annual basis to reach US$449.3 million in 2025.
The diabetes market in the country has experienced robust growth during 2020-2024, achieving a CAGR of 7.2%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 5.5% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 420.8 million to approximately USD 592.7 million.
This report provides a detailed data-centric analysis of the diabetes industry in Kenya, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics.
It breaks down market opportunities by industries, deployment models, and enterprise sizes. In addition, it provides a snapshot across combination drugs, route of administration. The report also segments the market by type of diabetes, distribution channels, offering insights into end user trends. KPIs in value terms help in gaining an in-depth understanding of end-market dynamics.
The research methodology is based on industry best practices. Its unbiased analysis leverages a proprietary analytics platform to offer a detailed view of emerging business and investment market opportunities.ScopeThis report provides an in-depth, data-centric analysis of the Latin America diabetes devices and therapeutics market 2020-2029. Below is a summary of key market segments:
The diabetes market in the country has experienced robust growth during 2020-2024, achieving a CAGR of 7.2%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 5.5% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 420.8 million to approximately USD 592.7 million.
This report provides a detailed data-centric analysis of the diabetes industry in Kenya, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics.
It breaks down market opportunities by industries, deployment models, and enterprise sizes. In addition, it provides a snapshot across combination drugs, route of administration. The report also segments the market by type of diabetes, distribution channels, offering insights into end user trends. KPIs in value terms help in gaining an in-depth understanding of end-market dynamics.
The research methodology is based on industry best practices. Its unbiased analysis leverages a proprietary analytics platform to offer a detailed view of emerging business and investment market opportunities.ScopeThis report provides an in-depth, data-centric analysis of the Latin America diabetes devices and therapeutics market 2020-2029. Below is a summary of key market segments:
Diabetes Devices and Therapeutics Market Share by Category
- Diagnosis and Monitoring Devices
- Therapeutics
Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices
- Blood Glucose Monitoring Devices
- Insulin Delivery Devices
- Diabetes Management and Mobile Applications
- Artificial Pancreas Devices
Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices
- Self-Monitoring Blood Glucose Devices
- Continuous Blood Glucose Monitoring Devices
- Test Strips
- Lancets
Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices
- Insulin Pumps
- Insulin Pens
- Insulin Syringes
Diabetes Devices and Therapeutics Market Share by Therapeutics
- Oral Anti-Diabetic Drugs
- Insulin
- Non-Insulin Injectable Drugs
- Combination Drugs
Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs
- Alpha-Glucosidase Inhibitors
- DPP-4 Inhibitors
- SGLT-2 Inhibitors
Diabetes Devices and Therapeutics Market Share by Insulin
- Basal or Long-Acting
- Bolus or Fast-Acting
- Traditional Human Insulin Drugs
- Insulin Biosimilars
Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs
- GLP-1 Receptor Agonists
- Amylin Analogue
Diabetes Devices and Therapeutics Market Share by Combination Drugs
- Combination Insulin
- Oral Combination
Diabetes Devices and Therapeutics Market Share by Route of Administration
- Subcutaneous
- Intravenous
- Others
Diabetes Devices and Therapeutics Market Share by Type of Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
Diabetes Devices and Therapeutics Market Share by Distribution Channels
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Diabetes Devices and Therapeutics Market Share by End User
- Hospitals
- Diabetes Clinics
- Homecare
Reasons to buy
- Comprehensive understanding of market structure and dynamics: Gain a detailed view of the diabetes devices and therapeutics market, including category-level segmentation (Diagnosis & Monitoring Devices and Therapeutics) and sub-segmentation by product type, route of administration, type of diabetes, distribution channel, and end user.
- Identify high-growth segments and strategic investment areas: Use segment-wise market sizing and forecasting to identify opportunities in areas such as continuous glucose monitoring, insulin delivery technologies, oral anti-diabetic drugs, and biosimilars. Tailor your market entry or expansion strategies accordingly.
- Benchmark performance across distribution and care settings: Access share analysis across online, hospital, and retail pharmacies, and evaluate usage patterns across hospitals, diabetes clinics, and homecare to support channel-specific planning and resource allocation.
Table of Contents
1 Kenya Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029
2 Kenya Diabetes Devices and Therapeutics Market Share by Category, 2020-2029
3 Kenya Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029
4 Kenya Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029
5 Kenya Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029
6 Kenya Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029
7 Kenya Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029
8 Kenya Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029
9 Kenya Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029
10 Kenya Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029
11 Kenya Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029
12 Kenya Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029
13 Kenya Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029
14 Kenya Diabetes Devices and Therapeutics Market Share by End User, 2020-2029
List of Tables
List of Figures
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 50 |
Published | March 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 477.8 Million |
Forecasted Market Value ( USD | $ 592.7 Million |
Compound Annual Growth Rate | 5.5% |
Regions Covered | Kenya |